These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7525960)

  • 41. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms.
    Buckheit RW; Lackman-Smith C; Snow MJ; Halliday SM; White EL; Ross LJ; Agrawal VK; Broom AD
    Antivir Chem Chemother; 1999 Jan; 10(1):23-32. PubMed ID: 10079876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The anti-HIV activity of beta-glycyrrhizic acid].
    Pliasunova OA; Egoricheva IN; Fediuk NV; Pokrovskiĭ AG; Baltina LA; Murinov IuI; Tolstikov GA
    Vopr Virusol; 1992; 37(5-6):235-8. PubMed ID: 1290221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
    Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphate derivatives of AZT display enhanced selectivity of action against HIV 1 by comparison to the parent nucleoside.
    McGuigan C; Nickson C; Petrik J; Karpas A
    FEBS Lett; 1992 Sep; 310(2):171-4. PubMed ID: 1397268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies.
    Hyde RM; Broom AD; Buckheit RW
    J Med Chem; 2003 May; 46(10):1878-85. PubMed ID: 12723951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.
    Velázquez S; Alvarez R; San-Félix A; Jimeno ML; De Clercq E; Balzarini J; Camarasa MJ
    J Med Chem; 1995 May; 38(10):1641-9. PubMed ID: 7538589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action.
    Balzarini J; Stevens M; De Clercq E; Schols D; Pannecouque C
    J Antimicrob Chemother; 2005 Feb; 55(2):135-8. PubMed ID: 15650002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action.
    Lagoja IM; Pannecouque C; Van Aerschot A; Witvrouw M; Debyser Z; Balzarini J; Herdewijn P; De Clercq E
    J Med Chem; 2003 Apr; 46(8):1546-53. PubMed ID: 12672256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
    Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
    Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and anti-HIV evaluation of D4T and D4T 5'-monophosphate prodrugs.
    Sergheraert C; Pierlot C; Tartar A; Henin Y; Lemaitre M
    J Med Chem; 1993 Apr; 36(7):826-30. PubMed ID: 8385224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
    Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.
    Cywin CL; Klunder JM; Hoermann M; Brickwood JR; David E; Grob PM; Schwartz R; Pauletti D; Barringer KJ; Shih CK; Sorge CL; Erickson DA; Joseph DP; Hattox SE
    J Med Chem; 1998 Jul; 41(16):2972-84. PubMed ID: 9685236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prospects in the treatment of AIDS. II. AZT and related compounds; practical conclusions].
    Grieb P
    Pol Arch Med Wewn; 1992; 87(4-5):316-23. PubMed ID: 1381825
    [No Abstract]   [Full Text] [Related]  

  • 60. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
    Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Greco G; Novellino E; Altamura S; Di Renzo L
    J Med Chem; 1996 Jul; 39(14):2672-80. PubMed ID: 8709096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.